http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CL-2018001434-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae10212794160b34478f0d05b6ab6fd7
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
filingDate 2018-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_838e208d68a8b3184300d442c1dc6fa7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0774b7ff9933db6eb8c72c09a9dcddc1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd102aedaa405ae6081cd7142702dd95
publicationDate 2018-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CL-2018001434-A1
titleOfInvention Cyclic therapy with 3- (5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl) -piperidin-2,6-dione
abstract METHODS TO TREAT, PREVENT AND / OR CONTROL THE CANCER, INCLUSIVE LYMPHOMA, THAT INCLUDE ADMINISTRATION TO A PATIENT OF 3- (5-AMINO-2-METHYL-4-OXO-4H-QUINAZOLIN-3-IL ) -PIPERIDIN-2,6-DIONA, OR AN ENANTIOMER OR AN ENANTIOMER MIXTURE OF THIS, OR A SALT, SOLVATO, HYDRATION, COCRISTAL, CLATRATE OR POLYMORPH OF THESE PHARMACEUTICALLY ACCEPTABLE THESE IN A CYCLIC THERAPY GUIDE.
priorityDate 2015-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24967599
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421809005

Total number of triples: 22.